Immune-Mediated Inflammatory Diseases Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Immune-Mediated Inflammatory Diseases Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune-Mediated Inflammatory Diseases Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune-Mediated Inflammatory Diseases Treatment Overall Market Size
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size: 2023 VS 2030
2.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune-Mediated Inflammatory Diseases Treatment Players in Global Market
3.2 Top Global Immune-Mediated Inflammatory Diseases Treatment Companies Ranked by Revenue
3.3 Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Companies
3.4 Top 3 and Top 5 Immune-Mediated Inflammatory Diseases Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Immune-Mediated Inflammatory Diseases Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune-Mediated Inflammatory Diseases Treatment Players in Global Market
3.6.1 List of Global Tier 1 Immune-Mediated Inflammatory Diseases Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Immune-Mediated Inflammatory Diseases Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune-Mediated Inflammatory Diseases Treatment Market Size Markets, 2023 & 2030
4.1.2 Targeted biologic therapies
4.1.3 Novel therapies
4.2 By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue & Forecasts
4.2.1 By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2024
4.2.2 By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2025-2030
4.2.3 By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune-Mediated Inflammatory Diseases Treatment Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Pharmacy Store
5.1.4 Online Pharmacy Stroe
5.2 By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue & Forecasts
5.2.1 By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2024
5.2.2 By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2025-2030
5.2.3 By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Immune-Mediated Inflammatory Diseases Treatment Market Size, 2023 & 2030
6.2 By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue & Forecasts
6.2.1 By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2024
6.2.2 By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2025-2030
6.2.3 By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030
6.3.2 US Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.3.3 Canada Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.3.4 Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030
6.4.2 Germany Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.3 France Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.4 U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.5 Italy Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.6 Russia Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.4.8 Benelux Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030
6.5.2 China Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.5.3 Japan Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.5.4 South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.5.6 India Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030
6.6.2 Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.6.3 Argentina Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030
6.7.2 Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.7.3 Israel Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
6.7.5 UAE Immune-Mediated Inflammatory Diseases Treatment Market Size, 2019-2030
7 Immune-Mediated Inflammatory Diseases Treatment Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.1.4 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Eli Lilly
7.2.1 Eli Lilly Company Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.2.4 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.2.5 Eli Lilly Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.3.4 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Bristol-Myers
7.4.1 Bristol-Myers Company Summary
7.4.2 Bristol-Myers Business Overview
7.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.4.4 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.4.5 Bristol-Myers Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.5.4 Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.6.4 Roche Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.6.5 Roche Key News & Latest Developments
7.7 Enlivex Therapeutics
7.7.1 Enlivex Therapeutics Company Summary
7.7.2 Enlivex Therapeutics Business Overview
7.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.7.4 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.7.5 Enlivex Therapeutics Key News & Latest Developments
7.8 Immune Pharmaceuticals
7.8.1 Immune Pharmaceuticals Company Summary
7.8.2 Immune Pharmaceuticals Business Overview
7.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.8.4 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.8.5 Immune Pharmaceuticals Key News & Latest Developments
7.9 Tanabe Pharma
7.9.1 Tanabe Pharma Company Summary
7.9.2 Tanabe Pharma Business Overview
7.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Major Product Offerings
7.9.4 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue in Global Market (2019-2024)
7.9.5 Tanabe Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Immune-Mediated Inflammatory Diseases Treatment Market Opportunities & Trends in Global Market
Table 2. Immune-Mediated Inflammatory Diseases Treatment Market Drivers in Global Market
Table 3. Immune-Mediated Inflammatory Diseases Treatment Market Restraints in Global Market
Table 4. Key Players of Immune-Mediated Inflammatory Diseases Treatment in Global Market
Table 5. Top Immune-Mediated Inflammatory Diseases Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Immune-Mediated Inflammatory Diseases Treatment Product Type
Table 9. List of Global Tier 1 Immune-Mediated Inflammatory Diseases Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune-Mediated Inflammatory Diseases Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Immune-Mediated Inflammatory Diseases Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Immune-Mediated Inflammatory Diseases Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Immune-Mediated Inflammatory Diseases Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Immune-Mediated Inflammatory Diseases Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2025-2030
Table 30. GlaxoSmithKline Company Summary
Table 31. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 32. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Eli Lilly Company Summary
Table 35. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 36. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Eli Lilly Key News & Latest Developments
Table 38. AstraZeneca Company Summary
Table 39. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 40. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. AstraZeneca Key News & Latest Developments
Table 42. Bristol-Myers Company Summary
Table 43. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 44. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Bristol-Myers Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 48. Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Sanofi Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 52. Roche Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Roche Key News & Latest Developments
Table 54. Enlivex Therapeutics Company Summary
Table 55. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 56. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Enlivex Therapeutics Key News & Latest Developments
Table 58. Immune Pharmaceuticals Company Summary
Table 59. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 60. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Immune Pharmaceuticals Key News & Latest Developments
Table 62. Tanabe Pharma Company Summary
Table 63. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product Offerings
Table 64. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Tanabe Pharma Key News & Latest Developments
List of Figures
Figure 1. Immune-Mediated Inflammatory Diseases Treatment Segment by Type in 2023
Figure 2. Immune-Mediated Inflammatory Diseases Treatment Segment by Application in 2023
Figure 3. Global Immune-Mediated Inflammatory Diseases Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2023
Figure 8. By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 16. US Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 28. China Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Immune-Mediated Inflammatory Diseases Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Sanofi Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Roche Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
